Document ID: chunk:federal_register_of_legislation:F2024C00866:clause:1_1:p6
Version: federal_register_of_legislation:F2024C00866
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 6/8)
Character Range: 26098–29772

trade marks, images, figures, logos or emblems, that are in contravention of another provision of this standard; or
                              (ii) any promotional statement, pictorial representation or design;
                           (g) a therapeutic vaping device or a therapeutic vaping device accessory must not include any features designed to change the appearance of the device, including the following:
                              (i) heat activated inks;
                              (ii) inks or embellishments designed to appear gradually over time;
                              (iii) inks that appear fluorescent in certain light;
                              (iv) panels designed to be scratched or rubbed to reveal an image or text
   11                    all of the following matters:
                           (a) a therapeutic vaping device or a therapeutic vaping device accessory must be supplied in a primary pack, where the label of the primary pack and the primary pack are white;
                           (b) any information on the label of the primary pack and the primary pack must be:
                              (i) in English; and
                              (ii) clearly legible; and
                              (iii) printed in a manner that is durable; and
                              (iv) in a text colour that is matte grey or matte black, unless required by an applicable standard to be another colour;
                           (c) the label of the primary pack and the primary pack must not contain the following:
                              (i) any feature that suggests, whether expressly or by implication, that the device has health benefits other than its intended purpose, including healing, vitalising, natural, organic, or rejuvenating properties;
                              (ii) any words, symbols, trade marks, images, figures, logos or emblems that are in contravention of another provision of this standard;
                              (iii) any promotional statement, pictorial representation or design;
                           (d) the label and packaging must not include any features designed to change the appearance of the primary pack, including the following:
                              (i) heat activated inks;
                              (ii) inks or embellishments designed to appear gradually over time;
                              (iii) inks that appear fluorescent in certain light;
                              (iv) panels designed to be scratched or rubbed to reveal an image or text;
                              (v) removable tabs;
                              (vi) fold out panels;
                           (e) the label of the primary pack must include the warning statements:
                             (i) "KEEP OUT OF REACH OF CHILDREN"; and
                             (ii) "WARNING CONTAINS BUTTON OR COIN BATTERY. HAZARDOUS IF SWALLOWED – SEE INSTRUCTIONS" (if applicable); and
                             (iii) "RISK OF FIRE OR EXPLOSION. REPLACE ONLY WITH THE SAME SIZE AND TYPE OF BATTERY" (if applicable);
                           (f) the warning statements required by paragraph (e) must be in bold‑face, sans serif, capital letters of uniform thickness and size
   12                    a therapeutic vaping device or a therapeutic vaping device accessory must be subject to a toxicological risk assessment of the emissions from the device, for the expected lifetime of the device, including but not limited to an assessment of all of the following, having regard to the generally acknowledged state of the art:
                           (a)